Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Heidrick & Struggles International Inc | 1 | 0 | 0 | 0 | €32.00 | €40.00 | 25.000% |
| Heron Therapeutics Inc. | 11 | 1 | 2 | 0 | €3.31 | €4.59 | 38.473% |
| Hibbett Sports Inc. | 1 | 0 | 0 | 0 | €79.50 | - | - |
| Hub Group Inc. | 11 | 1 | 0 | 0 | €39.20 | €80.13 | 104.412% |
| Hudson Global Inc. | 19 | 0 | 0 | 0 | €14.00 | - | - |
| Huron Consulting Group | 9 | 0 | 4 | 0 | €86.00 | €125.68 | 46.139% |
| Ichor Holdings Ltd | 9 | 0 | 1 | 0 | €35.00 | €38.98 | 11.384% |
| Immersion Corp. | 3 | 0 | 2 | 0 | €9.25 | €10.19 | 10.114% |
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |
| Impinj Inc | 19 | 2 | 3 | 0 | €152.50 | €150.40 | -1.377% |
| Infinera Corp. | 9 | 1 | 3 | 0 | €4.96 | €7.59 | 53.113% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.70 | €30.00 | 104.082% |
| Insight Enterprises | 8 | 0 | 1 | 0 | €181.60 | €195.68 | 7.754% |
| Insmed Inc. | 28 | 2 | 15 | 2 | €52.50 | €55.83 | 6.337% |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | €62.50 | €79.55 | 27.287% |
| Kala Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €6.05 | €19.50 | 222.556% |
| Kelly Services Inc. A | 5 | 0 | 2 | 0 | €19.90 | €26.77 | 34.522% |
| Key Tronic Corp. | 23 | 1 | 2 | 0 | €3.62 | - | - |
| Kinsale Capital Group Inc | 10 | 0 | 0 | 0 | €352.10 | €417.65 | 18.615% |
| Krystal Biotech | 18 | 0 | 2 | 0 | €148.15 | €179.60 | 21.225% |
| Kura Oncology Inc | 1 | 0 | 0 | 0 | €18.97 | €20.00 | 5.457% |
| Lakeland Industries Inc. | 3 | 0 | 0 | 0 | €18.80 | €20.58 | 9.485% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €75.88 | €80.00 | 5.430% |
| Lemaitre Vascular Inc | 2 | 0 | 1 | 0 | €70.50 | €73.50 | 4.255% |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 0 | 0 | €1.78 | €5.34 | 199.775% |